391 related articles for article (PubMed ID: 25404735)
1. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
Zhang M; Zhu B; Davie J
J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy.
Baruffaldi F; Montarras D; Basile V; De Feo L; Badodi S; Ganassi M; Battini R; Nicoletti C; Imbriano C; Musarò A; Molinari S
Stem Cells; 2017 Mar; 35(3):725-738. PubMed ID: 27612437
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
Zhu B; Gulick T
Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
[TBL] [Abstract][Full Text] [Related]
4. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
Zhang M; Truscott J; Davie J
Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
[TBL] [Abstract][Full Text] [Related]
5. Serine/Threonine Kinase 40 (Stk40) Functions as a Novel Regulator of Skeletal Muscle Differentiation.
He K; Hu J; Yu H; Wang L; Tang F; Gu J; Ge L; Wang H; Li S; Hu P; Jin Y
J Biol Chem; 2017 Jan; 292(1):351-360. PubMed ID: 27899448
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of Mef2c promoted by Fox-1 during neural differentiation in P19 cells.
Hakim NH; Kounishi T; Alam AH; Tsukahara T; Suzuki H
Genes Cells; 2010 Mar; 15(3):255-67. PubMed ID: 20141540
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition.
Badodi S; Baruffaldi F; Ganassi M; Battini R; Molinari S
Cell Cycle; 2015; 14(10):1517-28. PubMed ID: 25789873
[TBL] [Abstract][Full Text] [Related]
8. Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis.
Singh RK; Xia Z; Bland CS; Kalsotra A; Scavuzzo MA; Curk T; Ule J; Li W; Cooper TA
Mol Cell; 2014 Aug; 55(4):592-603. PubMed ID: 25087874
[TBL] [Abstract][Full Text] [Related]
9. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.
Zhu B; Zhang M; Byrum SD; Tackett AJ; Davie JK
Int J Cancer; 2014 Aug; 135(4):785-97. PubMed ID: 24470334
[TBL] [Abstract][Full Text] [Related]
10. Interaction of OIP5-AS1 with MEF2C mRNA promotes myogenic gene expression.
Yang JH; Chang MW; Pandey PR; Tsitsipatis D; Yang X; Martindale JL; Munk R; De S; Abdelmohsen K; Gorospe M
Nucleic Acids Res; 2020 Dec; 48(22):12943-12956. PubMed ID: 33270893
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
[TBL] [Abstract][Full Text] [Related]
12. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J
Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416
[TBL] [Abstract][Full Text] [Related]
13. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
14. Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb.
Ganassi M; Badodi S; Polacchini A; Baruffaldi F; Battini R; Hughes SM; Hinits Y; Molinari S
Biochim Biophys Acta; 2014 Jul; 1839(7):559-70. PubMed ID: 24844180
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation.
Sebastian S; Faralli H; Yao Z; Rakopoulos P; Palii C; Cao Y; Singh K; Liu QC; Chu A; Aziz A; Brand M; Tapscott SJ; Dilworth FJ
Genes Dev; 2013 Jun; 27(11):1247-59. PubMed ID: 23723416
[TBL] [Abstract][Full Text] [Related]
16. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.
Diao Y; Guo X; Jiang L; Wang G; Zhang C; Wan J; Jin Y; Wu Z
J Biol Chem; 2014 Jan; 289(1):529-39. PubMed ID: 24247238
[TBL] [Abstract][Full Text] [Related]
17. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.
Jacob AG; O'Brien D; Singh RK; Comiskey DF; Littleton RM; Mohammad F; Gladman JT; Widmann MC; Jeyaraj SC; Bolinger C; Anderson JR; Barkauskas DA; Boris-Lawrie K; Chandler DS
Neoplasia; 2013 Sep; 15(9):1049-63. PubMed ID: 24027430
[TBL] [Abstract][Full Text] [Related]
18. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
19. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
[TBL] [Abstract][Full Text] [Related]
20. Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.
Li S; Chen K; Zhang Y; Barnes SD; Jaichander P; Zheng Y; Hassan M; Malladi VS; Skapek SX; Xu L; Bassel-Duby R; Olson EN; Liu N
Genes Dev; 2019 Jun; 33(11-12):626-640. PubMed ID: 30975722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
